EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An engineered immunomodulatory IgG1 Fc suppresses autoimmune inflammation through pathways shared with i.v. immunoglobulin

Sunny L Sneed, Brian B Reese, Ana Fs Laureano, Sneha Ratnapriya, Isabella Fraschilla, Kate L Jeffrey, Greg P Coffey, Pamela B Conley, Robert M Anthony

Journal of Clinical Investigation · 2024

DOI: 10.1172/jci172980 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Sunny L Sneed und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, and. Hauptthemen laut MEDLINE: Immunoglobulin G, Immunoglobulins, Intravenous. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin GImmunoglobulins, IntravenousInfant, NewbornHumansImmunoglobulin Fc FragmentsInflammationReceptors, FcGlycosylation

Stichwörter der Autor:innen

Autoimmune diseasesImmunoglobulinsImmunologyImmunotherapy

Substanzen

Immunoglobulin GImmunoglobulins, IntravenousImmunoglobulin Fc FragmentsReceptors, Fc

Autor:innen und Institutionen

  • Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, and.
  • Center for the Study of Inflammatory Bowel Disease, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Nuvig Therapeutics, Redwood City, California, USA.

Förderung

  • NIDDK NIH HHS
  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • Nuvig Therapeutics

Zitieren

APA

Sneed, S. L., Reese, B. B., Laureano, A. F., Ratnapriya, S., Fraschilla, I., Jeffrey, K. L., Coffey, G. P., Conley, P. B., & Anthony, R. M. (2024). An engineered immunomodulatory IgG1 Fc suppresses autoimmune inflammation through pathways shared with i.v. immunoglobulin. Journal of Clinical Investigation. https://doi.org/10.1172/jci172980

Vancouver

Sneed SL, Reese BB, Laureano AF, Ratnapriya S, Fraschilla I, Jeffrey KL, et al. An engineered immunomodulatory IgG1 Fc suppresses autoimmune inflammation through pathways shared with i.v. immunoglobulin. Journal of Clinical Investigation. 2024. doi:10.1172/jci172980

BibTeX
@article{Sneed2024,
  author = {Sneed, Sunny L and Reese, Brian B and Laureano, Ana Fs and Ratnapriya, Sneha and Fraschilla, Isabella and Jeffrey, Kate L and Coffey, Greg P and Conley, Pamela B and Anthony, Robert M},
  title = {An engineered immunomodulatory IgG1 Fc suppresses autoimmune inflammation through pathways shared with i.v. immunoglobulin},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1172/jci172980}
}
Kostenlos starten →